Items where authors include "Kennedy, B."

Article

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Hailey, L., Bundy, C., Burstow, H. et al. (13 more authors) (2023) The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership. Rheumatology, 62 (8). pp. 2716-2723. ISSN 1462-0324

Hillmen, P., Pitchford, A., Bloor, A. et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Hailey, L. orcid.org/0000-0001-5769-8663, Bundy, C., Burstow, H. et al. (13 more authors) (2022) The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership. Rheumatology, 62 (8). pp. 2716-2723. ISSN 1462-0324

Rawstron, A.C., Kennedy, B., Moreton, P. et al. (5 more authors) (2004) Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemia. Blood, 103 (6). pp. 2027-2031. ISSN 0006-4971